Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Express Scripts
US Department of Justice

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,786,462

« Back to Dashboard

Title: High affinity ssDNA ligands of HIV-1 reverse transcriptase
Abstract:Methods are described for the identification and preparation of DNA ligands to the HIV-1 reverse transcriptase protein. Included in the invention are specific ssDNA ligands to HIV-1 reverse transcriptase identified by the SELEX method. Also included are ssDNA ligands that inhibit HIV-1 reverse transcriptase.
Inventor(s): Schneider; Daniel J. (Boulder, CO), Gold; Larry (Boulder, CO), Feigon; Juli (Los Angeles, CA)
Assignee: NeXstar Pharmaceuticals, Inc. (Boulder, CO)
Filing Date:May 17, 1995
Application Number:08/443,407
Claims:1. A purified and isolated non-naturally occurring DNA ligand to HIV-1 reverse transcriptase wherein said ligand is selected from the group consisting of the sequences set forth in SEQ ID NOS: 6-72 and 76-94.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.